Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A06537 | Pages: 199 | Charts: 34 | Tables: 117 |
The global butterfly needle sets market size is $166.60 million in 2019, and is expected to reach $320.02 million by 2027, registering a CAGR 8.20% from 2020 to 2027.
A butterfly needle is a device used to draw blood from an access vein or deliver intravenous (IV) therapy through a vein. These needles comprise hypodermic needle bilateral flexible wings and a connector, which is attached to a vacuum tube or collection bag to draw blood from an infusion pump. In addition, butterfly needles are advantageous to patients with bleeding disorders, such as hemophilia or von Willebrand disease. For instance, in the U.S., 17,757 people were diagnosed with hemophilia in 2018.Further, phlebotomists regularly use butterfly needles to obtain blood samples for complete blood counts (CBC), cholesterol tests, diabetes monitoring, STD screens, and other blood-based tests. These needles are also commonly used in blood banks for people who are there for blood donation. These needles are much easier to use and are less painful for patients. Thus, it reaches more body surface and tolerates more patient movement.
Get more information on this report : Request Sample Pages
The coronavirus disease (COVID-19) suddenly spread across the globe. Further, the increase in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced respiratory failure leading to COVID-19 disease, which has fueled the intensive care units (ICU) globally. Despite of that it has resulted in the several risks related to blood supply. For instance, there are several cases in which specific viral RNA could be detected in the serum from patients with COVID-19 and these findings suggested that blood donation may be an unexplored route of transmission. For instance, in March 20, 2020, WHO Guidance for National Blood Services on Protecting the Blood Supply during Infectious Disease Outbreaks. This has provided general guidance on the development of national plans to respond to any emerging infectious threats to the sufficiency or safety of the blood supply. Therefore, this resulted in the low impact of Covid-19 on the growth of butterfly needles market.
Major factors that drive the butterfly needle sets market growth are rise in prevalence of chronic diseases globally such as cancer, intravenous therapy, cardiovascular diseases, and bleeding disorders. In addition, need for managing long term medications and drug infusions are some of the other factors that boost growth of the market. However, lack of product innovations and regulatory standards and guidelines are required to be followed by phlebotomists hamper the market growth. Moreover, safety and convenience provided by these needles and treatments associated with butterfly needle, the market is expected to grow compared to the substitute products. In addition, in 2019, intraosseous needle trials were conducted for neonates (new born children), which has opened opportunities for new applications offer opportunities for the market growth during the forecast period.
The global butterfly needle blood collection set butterfly needle sets market is segmented on the basis of application, end user, and region. By application, it is segmented into blood transfusion, venipuncture, IV rehydration, and delivery of medications. By end user, it is segmented into hospitals, blood bank, and others. Region wise, the market is categorized into North America, Europe, Asia-Pacific, and LAMEA. These regions are further analyzed on the basis of respective countries.
[APPLICATIONGRAPH]
Get more information on this report : Request Sample Pages
On the basis of application, the blood transfusion segment dominated the butterfly needles set market, value in 2019, and its dominance in the market is expected to continue throughout the forecast period. This is attributed to increase in anemia and bleeding disorders such as hemophilia and cancer. In addition, rise in chemotherapy and geriatric patients whose veins are fragile and difficult to access leads to boost the blood transfusion segment in butterfly needle sets market growth.
[ENDUSERGRAPH]
Get more information on this report : Request Sample Pages
On the basis of end user, the blood donation segment dominated the butterfly needles set market in 2019, and is expected to continue its growth during the forecast period. Owing to increase in use of butterfly needles in blood donation banks & camps, and rise in population who are interested in blood donation.
[REGIONGRAPH]
Get more information on this report : Request Sample Pages
In 2019, Asia-Pacific accounted for largest butterfly needle sets market of the butterfly needles market and is expected to remain the highest revenue-generating region during the forecast period, owing to widespread adoption of butterfly needles, large pool of patients suffering from cancer and cardiovascular diseases, and rise in demand for blood transfusion. In addition, owing to rise in number of blood donors and increase in patient population across the region are further expected to boost the Asia-Pacific butterfly needle sets market. Further, North America was the second highest revenue-generating with a value $49.98 million in 2019 for butterfly needle sets market. Owing to as in 2018, around 17,757 people were diagnosed with hemophilia. In addition, Growth in healthcare awareness and well-established healthcare infrastructure and major key players for butterfly needles are expected to boost the growth of the market in North America for this market.
The global butterfly needles set market is highly competitive, and prominent players have adopted various strategies for garnering maximum butterfly needle sets market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Braun Melsungen AG, Becton, Dickinson and Company, Nipro Corporation, Cardinal Health, Inc., Medline Industries, Inc., Terumo Corporation, Kawasumi Laboratories, Inc., ISOMed, and BioMatrix S.r.l.
Key Benefits For Stakeholders
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits
1.3.Key market segments
1.4.Research methodology
1.4.1.Primary research
1.4.2.Secondary Research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.key findings of the study:
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Key findings
3.1.1.Top investment pockets
3.2.Porter’s five forces analysis
3.3.Market definition and scope
3.3.1.Impact Analysis
3.3.2.Drivers
3.3.2.1.Rise in prevalence of chronic diseases globally
3.3.2.2.Precise and easy use of butterfly needles set
3.3.2.3.Need for managing long term medication and drug infusion
3.3.3.Restraints
3.3.3.1.Lack of product innovation
3.3.3.2.Regulatory standards
3.3.4.Opportunities
3.3.4.1.Safety and convenience associated with butterfly needles
CHAPTER 4:BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY APPLICATION
4.1.Overview
4.1.1.Market size and forecast
4.2.Blood transfusion
4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market share analysis, by country
4.3.Venipuncture
4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market share analysis, by country
4.4.IV Rehydration
4.4.1.Key market trends, growth factors and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market share analysis, by country
4.5.Delivery of Medications
4.5.1.Key market trends, growth factors and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market share analysis, by country
CHAPTER 5:BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY END USER
5.1.Overview
5.1.1.Market size and forecast
5.2.Hospital
5.2.1.Market size and forecast, by region
5.2.2.Market share analysis, by country
5.3.Blood Bank
5.3.1.Market size and forecast, region
5.3.2.Market share analysis, by country
5.4.Others
5.4.1.Market size and forecast, by region
5.4.2.Market share analysis, by country
CHAPTER 6:BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.North America, by average selling price
6.2.3.North America, by market share analysis
6.2.4.North America market size and forecast, by country
6.2.5.North America market size and forecast, by application
6.2.6.North America market size and forecast, by end user
6.2.6.1.U.S.
6.2.6.1.1.U.S, by market share analysis
6.2.6.1.2.U.S. market size and forecast, by application
6.2.6.1.3.U.S. market size and forecast, by end user
6.2.6.2.Canada
6.2.6.2.1.Canada, by market share analysis
6.2.6.2.2.Canada market size and forecast, by application
6.2.6.2.3.Canada market size and forecast, by end user
6.2.6.3.Mexico
6.2.6.3.1.Mexico, by market share analysis
6.2.6.3.2.Mexico market size and forecast, by application
6.2.6.3.3.Mexico market size and forecast, by end user
6.3.Europe
6.3.1.Key market trends and opportunities
6.3.2.Europe, by average selling price
6.3.3.Europe, by market share analysis
6.3.4.Europe market size and forecast, by country
6.3.5.Europe market size and forecast, by application
6.3.6.Europe market size and forecast, by end user
6.3.6.1.Germany
6.3.6.1.1.Germany, by market share analysis
6.3.6.1.2.Germany market size and forecast, by application
6.3.6.1.3.Germany market size and forecast, by end user
6.3.6.2.UK
6.3.6.2.1.UK, by market share analysis
6.3.6.2.2.UK market size and forecast, by application
6.3.6.2.3.UK market size and forecast, by end user
6.3.6.3.France
6.3.6.3.1.France, by market share analysis
6.3.6.3.2.France market size and forecast, by application
6.3.6.3.3.France market size and forecast, by end user
6.3.6.4.Italy
6.3.6.4.1.Italy, by market share analysis
6.3.6.4.2.Italy market size and forecast, by application
6.3.6.4.3.Italy market size and forecast, by end user
6.3.6.5.Spain
6.3.6.5.1.Spain, by market share analysis
6.3.6.5.2.Spain market size and forecast, by application
6.3.6.5.3.Spain market size and forecast, by end user
6.3.6.6.Rest of Europe
6.3.6.6.1.Rest of Europe, by market share analysis
6.3.6.6.2.Rest of Europe market size and forecast, by application
6.3.6.6.3.Rest of Europe market size and forecast, by end user
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Asia-Pacific, by average selling price
6.4.3.Asia-Pacific, by market selling price
6.4.4.Asia-Pacific market size and forecast, by country
6.4.5.Asia-Pacific market size and forecast, by application
6.4.6.Asia-Pacific market size and forecast, by end user
6.4.6.1.India
6.4.6.1.1.India, by market share analysis
6.4.6.1.2.India market size and forecast, by application
6.4.6.1.3.India market size and forecast, by end user
6.4.6.2.China
6.4.6.2.1.China, by market share analysis
6.4.6.2.2.China market size and forecast, by application
6.4.6.2.3.China market size and forecast, by end user
6.4.6.3.Japan
6.4.6.3.1.Japan, by market share analysis
6.4.6.3.2.Japan market size and forecast, by application
6.4.6.3.3.Japan market size and forecast, by end user
6.4.6.4.Australia
6.4.6.4.1.Australia, by market share analysis
6.4.6.4.2.Australia market size and forecast, by application
6.4.6.4.3.Australia market size and forecast, by end user
6.4.6.5.South Korea
6.4.6.5.1.South Korea, by market share analysis
6.4.6.5.2.South Korea market size and forecast, by application
6.4.6.5.3.South Korea market size and forecast, by end user
6.4.6.6.Rest of Asia-Pacific
6.4.6.6.1.Rest of Asia-Pacific, by market share analysis
6.4.6.6.2.Rest of Asia-Pacific market size and forecast, by application
6.4.6.6.3.Rest of Asia-Pacific market size and forecast, by end user
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.LAMEA, by average selling price
6.5.3.LAMEA, by market share analysis
6.5.4.LAMEA market size and forecast, by country
6.5.5.LAMEA market size and forecast, by application
6.5.6.LAMEA market size and forecast, by end user
6.5.6.1.Brazil
6.5.6.1.1.Brazil, by market share analysis
6.5.6.1.2.Brazil market size and forecast, by application
6.5.6.1.3.Brazil market size and forecast, by end user
6.5.6.2.Saudi Arabia
6.5.6.2.1.Saudi Arabia, by market share analysis
6.5.6.2.2.Saudi Arabia market size and forecast, by application
6.5.6.2.3.Saudi Arabia market size and forecast, by end user
6.5.6.3.South Africa
6.5.6.3.1.South Africa, by market share analysis
6.5.6.3.2.South Africa market size and forecast, by application
6.5.6.3.3.South Africa market size and forecast, by end user
6.5.6.4.Rest of LAMEA
6.5.6.4.1.Rest of LAMEA, by market share analysis
6.5.6.4.2.Rest of LAMEA market size and forecast, by application
6.5.6.4.3.Rest of LAMEA market size and forecast, by end user
CHAPTER 7:COMAPANY PROFILES
7.1.B. BRAUN MELSUNGEN AG
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.2.BECTON, DICKINSON AND COMPANY
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.3.NIPRO CORPORATION (NIPRO MEDICAL CORPORATION)
7.3.1.Company overview
7.3.2.Operating business segments
7.3.3.Product portfolio
7.3.4.Business performance
7.4.CARDINAL HEALTH INC.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.5.MEDLINE INDUSTRIES, INC.
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.6.TERUMO CORPORATION (TERUMO MEDICAL CORPORATION)
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.KAWASUMI LABORATORIES, INC. (KAWASUMI LABORATORIES AMERICA, INC.)
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.8.ISOMED
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.9.BIOMATRIX S.R.L.
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.10.SMITH’S GROUP PLC
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
LIST OF TABLES
TABLE 01.BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 02.BLOOD TRANSFUSION BUTTERFLY NEEDLE SETS, BY REGION, 2019–2027 ($MILLION)
TABLE 03.VENIPUNCTURE BUTTERFLY NEEDLE SETS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.IV DEHYDERATION BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 05.DELIVERY OF MEDICATION BUTTERFLY NEEDLE SETS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 07.HOSPITAL NEEDLE BLOOD COLLECTION SET MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 08.BLOOD BANK BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.OTHERS BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 10.GLOBAL BUTTERFLY NEEDLE SET MARKET, BY REGION 2019-2027 ($MILLION)
TABLE 11.AVERAGE SELLING PRICE OF NORTH AMERICA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 12.MARKET SHARE ANALYSIS OF NORTH AMERICA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 13.NORTH AMERICA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 14.NORTH AMERICA BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 15.NORTH AMERICA BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 16.MARKET SHARE ANALYSIS OF U.S BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 17.U.S. BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 18.U.S. BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 19.MARKET SHARE ANALYSIS OF CANADA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 20.CANADA BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 21.CANADA BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 22.MARKET SHARE ANALYSIS OF MEXICO BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 23.MEXICO BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 24.MEXICO BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 25.AVERAGE SELLING PRICE OF EUROPE BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 26.MARKET SHARE ANALYSIS OF EUROPE BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 27.EUROPE BUTTERFLY NEEDLE SET MARKET, BY COUNTRY 2019–2027 ($MILLION)
TABLE 28.EUROPE BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 29.EUROPE BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 30.MARKET SHARE ANALYSIS OF GERMANY BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 31.GERMANY BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 32.GERMANY BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 33.MARKET SHARE ANALYSIS OF UK BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 34.UK BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 35.UK BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 36.MARKET SHARE ANALYSIS OF FRANCE BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 37.FRANCE BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 38.FRANCE BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 39.MARKET SHARE ANALYSIS OF ITALY BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 40.ITALY BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 41.ITALY BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 42.MARKET SHARE ANALYSIS OF SPAIN BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 43.SPAIN BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 44.SPAIN BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 45.MARKET SHARE ANALYSIS OF REST OF EUROPE BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 46.REST OF EUROPE BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 47.REST OF EUROPE BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 48.AVERAGE SELLING PRICE OF ASIA-PACIFIC BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 49.MARKET SELLING PRICE OF ASIA-PACIFIC BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 50.ASIA-PACIFIC BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 51.ASIA-PACIFIC BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 52.ASIA-PACIFIC BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 53.MARKET SHARE ANALYSIS OF INDIA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 54.INDIA BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 55.INDIA BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 56.MARKET SHARE ANALYSIS OF CHINA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 57.CHINA BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 58.CHINA BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 59.MARKET SHARE ANALYSIS OF JAPAN BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 60.JAPAN BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 61.JAPAN BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 62.MARKET SHARE ANALYSIS OF AUSTRALIA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 63.AUSTRALIA BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 64.AUSTRALIA BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 65.MARKET SHARE ANALYSIS OF SOUTH KOREA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 66.SOUTH KOREA BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 67.SOUTH KOREA BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 68.MARKET SHARE ANALYSIS OF SOUTH KOREA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 69.REST OF ASIA- PACIFIC BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 71.AVERAGE SELLING PRICE OF LAMEA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 72.MARKET SHARE ANALYSIS OF LAMEA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 73.LAMEA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 74.LAMEA BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 75.LAMEA BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 76.MARKET SHARE ANALYSIS OF BRAZIL BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 77.BRAZIL BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 78.BRAZIL BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 79.MARKET SHARE ANALYSIS OF SAUDI ARABIA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 80.SAUDI ARABIA BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 81.SAUDI ARABIA BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 82.MARKET SHARE ANALYSIS OF SOUTH AFRICA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 83.SOUTH AFRICA BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 84.SOUTH AFRICA BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 85.MARKET SHARE ANALYSIS OF REST OF LAMEA BUTTERFLY NEEDLE SET MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 86.REST OF LAMEA BUTTERFLY NEEDLE SET MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 87.REST OF LAMEA BUTTERFLY NEEDLE SET MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 88.B. BRAUN: COMPANY SNAPSHOT
TABLE 89.B. BRAUN: BUSINESS SEGMENTS
TABLE 90.B. BRAUN: PRODUCT PORTFOLIO
TABLE 91.BD: SNAPSHOT
TABLE 92.BD: OPERATING SEGMENTS
TABLE 93.BD: PRODUCT PORTFOLIO
TABLE 94.NIPRO: COMPANY SNAPSHOT
TABLE 95.NIPRO: OPERATING SEGMENTS
TABLE 96.NIPRO: PRODUCT PORTFOLIO
TABLE 97.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 98.CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 99.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 100.MEDLINE: SNAPSHOT
TABLE 101.MEDLINE: OPERATING SEGMENTS
TABLE 102.MEDLINE: PRODUCT PORTFOLIO
TABLE 103.TERUMO: COMPANY SNAPSHOT
TABLE 104.TERUMO: OERATING SEGMENT
TABLE 105.TERUMO: PRODUCT PORTFOLIO
TABLE 106.KAWASUMI: COMPANY SNAPSHOT
TABLE 107.KAWASUMI: OPERATING SEGMENTS
TABLE 108.KAWASUMI: PRODUCT PORTFOLIO
TABLE 109.ISOMED: SNAPSHOT
TABLE 110.ISOMED: OPERATING SEGMENTS
TABLE 111.ISOMED: PRODUCT PORTFOLIO
TABLE 112.BIOMATRIX: COMPANY SNAPSHOT
TABLE 113.BIOMATRIX: OPERATING SEGMENTS
TABLE 114.BIOMATRIX: PRODUCT PORTFOLIO
TABLE 115.SMITHS MEDICAL: COMPANY SNAPSHOT
TABLE 116.SMITHS MEDICAL: OPERATING SEGMENTS
TABLE 117.SMITHS MEDICAL: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.TOP INVESTMENT POCKETS IN BUTTERFLY NEEDLES SET MARKET, 2019
FIGURE 02.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.MODERATE THREAT OF SUBSTITUTION
FIGURE 05.HIGH THREAT OF NEW ENTRANT
FIGURE 06.MODERATE COMPETITIVE RIVALRY
FIGURE 07.COMPARATIVE SHARE ANALYSIS OF BLOOD TRANSFUSION BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 08.COMPARATIVE SHARE ANALYSIS OF ASTHMA VENIPUNCTURE BLOOD COLLECTION SET MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 09.COMPARATIVE SHARE ANALYSIS OF IV DEHYDERATION BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF MEDICATION BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF HOSPITAL BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF BLOOD BANK BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF OTHERS BUTTERFLY NEEDLE BLOOD COLLECTION SET MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 14.B. BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 15.B. BRAUN: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 16.B. BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 17.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 18.BD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 19.BD: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 20.NIPRO: NET SALES, 2017–2019 ($MILLION)
FIGURE 21.NIPRO: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 22.NIPRO: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 23.CARDINAL HEALTH: NET SALES, 2017–2019 ($MILLION)
FIGURE 24.CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 25.CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 26.TERUMO: NET SALES, 2017–2019 ($MILLION)
FIGURE 27.TERUMO: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 28.TERUMO: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 29.KAWASUMI: NET SALES, 2017–2019 ($MILLION)
FIGURE 30.KAWASUMI: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 31.KAWASUMI: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 32.SMITHS MEDICAL: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.SMITHS MEDICAL: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 34.SMITHS MEDICAL: REVENUE SHARE, BY REGION, 2019 (%)
